WhiteHorse Finance (NASDAQ:WHF – Get Free Report) and Advanced Medical Isotope (OTCMKTS:RDGL – Get Free Report) are both small-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.
Institutional & Insider Ownership
13.2% of WhiteHorse Finance shares are held by institutional investors. 2.5% of WhiteHorse Finance shares are held by company insiders. Comparatively, 18.5% of Advanced Medical Isotope shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Analyst Ratings
This is a summary of current ratings and price targets for WhiteHorse Finance and Advanced Medical Isotope, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| WhiteHorse Finance | 2 | 3 | 0 | 0 | 1.60 |
| Advanced Medical Isotope | 0 | 0 | 0 | 0 | 0.00 |
Profitability
This table compares WhiteHorse Finance and Advanced Medical Isotope’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| WhiteHorse Finance | 12.91% | 9.93% | 4.14% |
| Advanced Medical Isotope | -6,144.90% | N/A | -113.56% |
Risk and Volatility
WhiteHorse Finance has a beta of 0.56, meaning that its stock price is 44% less volatile than the S&P 500. Comparatively, Advanced Medical Isotope has a beta of -0.5, meaning that its stock price is 150% less volatile than the S&P 500.
Valuation & Earnings
This table compares WhiteHorse Finance and Advanced Medical Isotope”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| WhiteHorse Finance | $92.82 million | 1.78 | $10.85 million | $0.43 | 16.49 |
| Advanced Medical Isotope | $30,000.00 | 1,008.15 | -$2.91 million | N/A | N/A |
WhiteHorse Finance has higher revenue and earnings than Advanced Medical Isotope.
Summary
WhiteHorse Finance beats Advanced Medical Isotope on 9 of the 11 factors compared between the two stocks.
About WhiteHorse Finance
WhiteHorse Finance, Inc. is business development company, non-diversified, closed end management company specializing in originating senior secured loans, lower middle market, growth capital industries. It invests in broadline retail, office services and supplies, building products, health care services, health care supplies, research and consulting services, application software, home furnishings, specialized consumer services, data processing and outsourced services, leisure facilities, cable, and satellite. It prefers to invest in United States. It typically invests between $5 million to $25 million in companies having enterprise value of between $50 million and $350 million.
About Advanced Medical Isotope
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.
Receive News & Ratings for WhiteHorse Finance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WhiteHorse Finance and related companies with MarketBeat.com's FREE daily email newsletter.
